HK1003573A1 - New antibiotics of the mureidomycin group their preparation and their therapeutic use - Google Patents

New antibiotics of the mureidomycin group their preparation and their therapeutic use

Info

Publication number
HK1003573A1
HK1003573A1 HK98102695A HK98102695A HK1003573A1 HK 1003573 A1 HK1003573 A1 HK 1003573A1 HK 98102695 A HK98102695 A HK 98102695A HK 98102695 A HK98102695 A HK 98102695A HK 1003573 A1 HK1003573 A1 HK 1003573A1
Authority
HK
Hong Kong
Prior art keywords
group
carbon atoms
mureidomycin
compound
new antibiotics
Prior art date
Application number
HK98102695A
Other languages
English (en)
Inventor
Tatsuo Haneishi
Masatoshi Inukai
Keiko Shimizu
Fujio Isono
Yoshiharu Sakaida
Takeshi Kinoshita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HK1003573A1 publication Critical patent/HK1003573A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98102695A 1987-11-20 1998-03-30 New antibiotics of the mureidomycin group their preparation and their therapeutic use HK1003573A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335287 1987-11-20
JP29335387 1987-11-20

Publications (1)

Publication Number Publication Date
HK1003573A1 true HK1003573A1 (en) 1998-10-30

Family

ID=26559375

Family Applications (2)

Application Number Title Priority Date Filing Date
HK98102695A HK1003573A1 (en) 1987-11-20 1998-03-30 New antibiotics of the mureidomycin group their preparation and their therapeutic use
HK98104839A HK1005736A1 (en) 1987-11-20 1998-06-03 Intermediates of the mureidomycin group their preparation and their use

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK98104839A HK1005736A1 (en) 1987-11-20 1998-06-03 Intermediates of the mureidomycin group their preparation and their use

Country Status (8)

Country Link
US (1) US5041423A (de)
EP (2) EP0517345B1 (de)
KR (2) KR0137779B1 (de)
AT (1) ATE125256T1 (de)
CA (1) CA1339595C (de)
DE (2) DE3880092T2 (de)
ES (2) ES2077345T3 (de)
HK (2) HK1003573A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487756A1 (de) * 1990-11-26 1992-06-03 Hoechst Aktiengesellschaft Antibiotika-Napsamycin A-D, deren Herstellung und pharmazeutische Verwendung
US6228842B1 (en) 1998-11-06 2001-05-08 Microcide Pharmaceuticals, Inc. Pacidamycins produced by Streptomyces coeruleorubidus
US6482921B1 (en) * 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
ATE316146T1 (de) * 2001-09-27 2006-02-15 Biocon Ltd Verfahren zur herstellung von pravastatin- natriumsalz mittels streptomyces flavidovirens dsm 14455
KR102302414B1 (ko) 2014-06-20 2021-09-16 주식회사 만도 임피던스 저감을 위한 피씨비와 섀시간의 그라운드 결합구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
GB8421279D0 (en) * 1984-08-22 1984-09-26 Baldwin J E Antibiotics
IT1184164B (it) * 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
ES2060587T3 (es) * 1986-05-20 1994-12-01 Sankyo Co Un procedimiento para producir los compuestos llamados mureidomicina a,b,c o d y sus sales y esteres.

Also Published As

Publication number Publication date
EP0517345B1 (de) 1995-07-19
ATE125256T1 (de) 1995-08-15
KR890008130A (ko) 1989-07-08
DE3854205T2 (de) 1996-04-04
ES2054829T3 (es) 1994-08-16
US5041423A (en) 1991-08-20
EP0317292A2 (de) 1989-05-24
EP0317292A3 (en) 1990-07-25
EP0517345A1 (de) 1992-12-09
EP0317292B1 (de) 1993-04-07
DE3880092T2 (de) 1993-11-25
HK1005736A1 (en) 1999-01-22
DE3880092D1 (de) 1993-05-13
ES2077345T3 (es) 1995-11-16
DE3854205D1 (de) 1995-08-24
KR0137675B1 (ko) 1998-05-15
CA1339595C (en) 1997-12-23
KR0137779B1 (ko) 1998-05-15

Similar Documents

Publication Publication Date Title
AU583439B2 (en) Prodrugs of rapamycin
AU8682191A (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
HK1012423A1 (en) Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
AU7124391A (en) Condensed thiazole compounds, their production and use
ZA902378B (en) Cephalos porins and their homologues process for their preparation and pharmaceutical compositions
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
NO174848C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
HK1003573A1 (en) New antibiotics of the mureidomycin group their preparation and their therapeutic use
AU608643B2 (en) Novel derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them
ZA894470B (en) Substituted 3-aminosydnone imines,a process for their preparation and their use
HUT44268A (en) Process for preparing compounds with construction similar to antibiotic tan-749
ES8205220A1 (es) Procedimiento para la obtencion de esteres del acido succi- nico de efecto antibacterial y antiprotozoal
ES8506313A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)